Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link

Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.

Volume 31, Number 6—June 2025

Research

Prospective Multicenter Surveillance of Non–H. pylori Helicobacter Infections during Medical Checkups, Japan, 2022

Kengo Tokunaga1Comments to Author , Emiko Rimbara1Comments to Author , Toshihisa Tsukadaira, Katsuhiro Mabe, Koji Yahara, Hidekazu Suzuki, Tadashi Shimoyama, Mitsushige Sugimoto, Tadayoshi Okimoto, Hidenori Matsui, Masato Suzuki, Keigo Shibayama, Hiroyoshi Ota, Kazunari Murakami, and Mototsugu Kato
Author affiliation: Kyorin University School of Medicine, Tokyo, Japan (K. Tokunaga); National Institute of Infectious Diseases, Tokyo (E. Rimbara, K. Yahara, H. Matsui, M. Suzuki); Kenwakai Hospital, Iida, Japan (T. Tsukadaira); Mabe Goryokaku Gastrointestinal Endoscopy Clinic, Hakodate, Japan (K. Mabe); Tokai University School of Medicine, Isehara, Japan (H. Suzuki); Aomori General Health Examination Center, Aomori, Japan (T. Shimoyama); Oita University, Oita, Japan (M. Sugimoto, K. Murakami); Oita Prefectural Hospital, Oita (T. Okimoto); Nagoya University Graduate School of Medicine, Nagoya, Japan (K. Shibayama); Shinshu University School of Medicine, Matsumoto, Japan (H. Ota); Public Interest Foundation Hokkaido Cancer Society, Sapporo, Japan (M. Kato)

Main Article

Table 3

Comparison of clinical characteristics between groups stratified by gastric Helicobacter species infection status in study of NHPH infections, Japan, 2022*

Characteristics Gastric Helicobacter species infection status
No Helicobacter infection H. pylori infection Posteradication Non–H. suis NHPH infection H. suis infection
Total no. patients
 378
 21
 254
 6
 14
Median age, y (range)
 53 (29–84)
 61 (35–88)
 57 (30–84)
 65 (44–91)
 50 (35–66)
Sex
M 224 (59.3) 10 (47.6) 139 (54.5) 3 (50.0) 14 (100.0)
F
 154 (40.7)
 11 (52.4)
 115 (45.3)
 3 (50.0)
 0
Endoscopic findings
Normal 317 (83.9) 0 5 (2.0) 0 0
Atrophic gastritis 53 (14.0) 21 (100.0) 248 (97.6) 4 (66.7) 14 (100)
Peptic ulcer 0 2 (9.5) 2 (0.8) 1 (16.7) 0
Gastric cancer 2 (0.5) 2 (9.5) 3 (1.2) 0 0
Nodular gastritis 0 4 (19.0) 7 (2.8) 3 (50.0) 6 (42.9)
White marble appearance 15 (4.0) 4 (19.0) 49 (19.3) 1 (16.7) 11 (78.6)
Crack-like mucosa 29 (7.7) 3 (14.3) 22 (8.7) 1 (16.7) 12 (85.7)
White marble appearance or crack-like mucosa
 40 (10.6)
 6 (28.6)
 70 (27.6)
 2 (33.3)
 13 (92.9)
Atrophic grading†
C-0 325 (86.0) 0 6 (2.4) 2 (33.3) 0
C-1 47 (12.4) 2 (9.5) 80 (31.5) 0 4 (28.6)
C-2 5 (1.3) 10 (47.6) 88 (34.6) 3 (50.0) 10 (71.4)
C-3 0 6 (28.6) 31 (12.2) 0 0
O-1 0 1 (4.8) 21 (8.3) 0 0
O-2 0 2 (9.5) 18 (7.1) 1 (16.7) 0
O-3
 1 (0.3)
 0
 10 (3.9)
 0
 0
Pets
No history 128 (33.9) 3 (14.3) 71 (28.0) 2 (33.3) 4 (28.6)
Dog 189 (50.0) 11 (52.4) 145 (57.1) 1 (16.7) 8 (57.1)
Cat
 75 (19.8)
 9 (42.9)
 58 (22.8)
 3 (50.0)
 3 (21.4)
Pork offal ingestion
No history 147 (38.9) 6 (28.6) 119 (46.9) 3 (50.0) 0
Sometimes 206 (54.5) 14 (66.7) 113 (44.5) 2 (33.3) 12 (85.7)
Often 25 (6.6) 1 (4.8) 22 (8.7) 1 (16.7) 2 (14.3)

*Values are no. (%) except as indicated. NHPH, non–Helicobacter pylori Helicobacter. †C-0, no atrophy; C-1 and C-2, mild atrophy; C-3 and O-1, moderate atrophy; and O-2 and O-3, severe atrophy.

Main Article

1These authors contributed equally to this article.

Page created: March 31, 2025
Page updated: May 13, 2025
Page reviewed: May 13, 2025
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external